Is Pharmacology Difficult Podcast BETA RECEPTOR AGONIST DRUGS

Is Pharmacology Difficult Podcast BETA RECEPTOR AGONIST DRUGS

18 Minuten

Beschreibung

vor 2 Jahren

Welcome all to IS PHARMACOLOGY DIFFICULT
Podcast! I am Dr Radhika Vijay.





This is again a coming of time episode in February. Its
fortnightly occurrence reveals a little hectic start of the
month.





Well, in today's episode I will be majorly talking
about Beta 2 receptor agonist
drugs which are short acting. To begin the
discussions, I talk about Dobutamine, the
rest of the List is long and covers agents
like Metaproterenol, Albuterol, Terbutaline,
Pirbuterol, Levalbuterol, Fenoterol, Isoetharine, and
Procaterol.





I will be covering the features, structural aspects, metabolism,
duration of action, effects, uses and adverse effects of these
drugs and the highlight points for which they are known for. Last
three mentioned drugs are in fact withdrawn, unavailable or have
some issues in regard of their efficacy.





With this detailed account of Short acting beta 2 receptor
agonists, I will be wrapping up this episode and will be
returning back with the account of Long acting beta 2 receptor
agonists.





For all the updates and latest episodes of my podcast, please
visit www.ispharmacologydifficult.com where
you can also sign up for a free monthly newsletter of mine. It
actually contains lot of updates about the medical sciences, drug
information and my podcast updates also.





You can follow me on different social media handles like twitter,
insta, facebook and linkedin. They all are with same name
"IS PHARMACOLOGY DIFFICULT". If you are
listening for the first time, do follow me here, whatever
platform you are consuming this episode, stay tuned, do rate and
review on ITunes, Apple podcasts, stay safe, stay happy, stay
enlightened, Thank you!!


You can access various links
via- https://linktr.ee/ispharmacologydifficult


Please leave Review on Apple podcasts!

Connect on Twitter & Instagram!

My books on Amazon & Goodreads!




Kommentare (0)

Lade Inhalte...

Abonnenten

15
15